OXYGENTA PHARMACEUTICAL
|
OXYGENTA PHARMACEUTICAL Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-1.53 Cr | ₹-4.64 Cr | ₹4.55 Cr | ₹-6.39 Cr | ₹1.08 Cr |
Raw Material Consumed | ₹35 Cr | ₹29 Cr | ₹43 Cr | ₹43 Cr | ₹15 Cr |
Opening Raw Materials | ₹3.75 Cr | ₹3.97 Cr | ₹4.25 Cr | ₹2.75 Cr | ₹2.78 Cr |
Purchases Raw Materials | ₹36 Cr | ₹28 Cr | ₹42 Cr | ₹45 Cr | ₹14 Cr |
Closing Raw Materials | ₹4.24 Cr | ₹3.75 Cr | ₹3.97 Cr | ₹4.25 Cr | ₹2.75 Cr |
Other Direct Purchases / Brought in cost | - | - | - | - | - |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹4.15 Cr | ₹4.16 Cr | ₹3.04 Cr | ₹2.79 Cr | ₹1.00 Cr |
Electricity & Power | ₹4.15 Cr | ₹4.16 Cr | ₹3.04 Cr | ₹2.79 Cr | ₹1.00 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹5.87 Cr | ₹5.74 Cr | ₹0.92 Cr | ₹4.08 Cr | ₹2.50 Cr |
Salaries, Wages & Bonus | ₹5.17 Cr | ₹5.46 Cr | ₹0.33 Cr | ₹3.89 Cr | ₹2.47 Cr |
Contributions to EPF & Pension Funds | ₹0.35 Cr | ₹0.21 Cr | ₹0.21 Cr | ₹0.18 Cr | - |
Workmen and Staff Welfare Expenses | ₹0.03 Cr | ₹0.02 Cr | ₹0.34 Cr | ₹0.02 Cr | - |
Other Employees Cost | ₹0.33 Cr | ₹0.06 Cr | ₹0.04 Cr | - | ₹0.02 Cr |
Other Manufacturing Expenses | ₹3.28 Cr | ₹2.43 Cr | ₹5.97 Cr | ₹2.88 Cr | ₹1.32 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹0.87 Cr | ₹0.78 Cr | ₹4.14 Cr | ₹0.58 Cr | - |
Repairs and Maintenance | ₹0.70 Cr | ₹0.10 Cr | ₹0.48 Cr | ₹0.98 Cr | ₹0.43 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹1.72 Cr | ₹1.56 Cr | ₹1.35 Cr | ₹1.32 Cr | ₹0.89 Cr |
General and Administration Expenses | ₹2.36 Cr | ₹1.72 Cr | ₹1.88 Cr | ₹1.78 Cr | ₹1.12 Cr |
Rent , Rates & Taxes | ₹0.23 Cr | ₹0.96 Cr | ₹0.27 Cr | ₹0.36 Cr | ₹0.09 Cr |
Insurance | ₹0.05 Cr | ₹0.05 Cr | ₹0.12 Cr | ₹0.07 Cr | ₹0.06 Cr |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹0.41 Cr | ₹0.22 Cr | ₹0.46 Cr | ₹0.22 Cr | ₹0.04 Cr |
Traveling and conveyance | ₹0.01 Cr | ₹0.05 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹0.03 Cr |
Other Administration | ₹1.66 Cr | ₹0.44 Cr | ₹1.03 Cr | ₹1.11 Cr | ₹0.92 Cr |
Selling and Distribution Expenses | ₹0.11 Cr | ₹0.04 Cr | ₹0.00 Cr | ₹0.01 Cr | ₹0.05 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | - | - | - | - | - |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹0.11 Cr | ₹0.04 Cr | ₹0.00 Cr | ₹0.01 Cr | ₹0.05 Cr |
Miscellaneous Expenses | ₹0.02 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | ₹0.01 Cr | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹49 Cr | ₹38 Cr | ₹59 Cr | ₹48 Cr | ₹22 Cr |
Operating Profit (Excl OI) | ₹-9.70 Cr | ₹-7.12 Cr | ₹1.48 Cr | ₹3.84 Cr | ₹-7.87 Cr |
Other Income | ₹0.04 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.09 Cr | ₹0.03 Cr |
Interest Received | ₹0.02 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.02 Cr | ₹0.02 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹0.03 Cr | ₹0.01 Cr | - | - | - |
Others | - | - | - | ₹0.07 Cr | ₹0.01 Cr |
Operating Profit | ₹-9.65 Cr | ₹-7.10 Cr | ₹1.48 Cr | ₹3.93 Cr | ₹-7.83 Cr |
Interest | ₹1.59 Cr | ₹1.49 Cr | ₹0.93 Cr | ₹1.78 Cr | ₹1.09 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹0.49 Cr | ₹0.59 Cr | ₹0.87 Cr | ₹1.46 Cr | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.00 Cr |
Other Interest | ₹1.10 Cr | ₹0.89 Cr | ₹0.05 Cr | ₹0.31 Cr | ₹1.09 Cr |
PBDT | ₹-11 Cr | ₹-8.59 Cr | ₹0.56 Cr | ₹2.15 Cr | ₹-8.93 Cr |
Depreciation | ₹2.66 Cr | ₹2.05 Cr | ₹1.59 Cr | ₹1.20 Cr | ₹1.00 Cr |
Profit Before Taxation & Exceptional Items | ₹-14 Cr | ₹-11 Cr | ₹-1.04 Cr | ₹0.96 Cr | ₹-9.93 Cr |
Exceptional Income / Expenses | ₹0.04 Cr | ₹-0.73 Cr | ₹0.55 Cr | ₹2.19 Cr | ₹3.99 Cr |
Profit Before Tax | ₹-14 Cr | ₹-11 Cr | ₹-0.49 Cr | ₹3.14 Cr | ₹-5.94 Cr |
Provision for Tax | ₹-10 Cr | ₹0.20 Cr | ₹0.12 Cr | ₹0.21 Cr | ₹-0.15 Cr |
Current Income Tax | - | - | - | - | - |
Deferred Tax | ₹-10 Cr | ₹0.20 Cr | ₹0.12 Cr | ₹0.21 Cr | ₹-0.15 Cr |
Other taxes | - | - | - | - | - |
Profit After Tax | ₹-3.48 Cr | ₹-12 Cr | ₹-0.61 Cr | ₹2.93 Cr | ₹-5.79 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹-60 Cr | ₹-49 Cr | ₹-48 Cr | ₹-51 Cr | ₹-45 Cr |
Appropriations | ₹-64 Cr | ₹-60 Cr | ₹-49 Cr | ₹-48 Cr | ₹-51 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | - | - | - | - |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹-1.04 | ₹-8.15 | ₹-0.43 | ₹2.87 | ₹-5.67 |
Adjusted EPS | ₹-1.04 | ₹-8.15 | ₹-0.43 | ₹2.87 | ₹-5.67 |
Compare Income Statement of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹292.0 Cr | -2.3% | 3.2% | 174.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -2.3% |
3.2% |
174.7% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses